Berry-Kravis E - Search Results

1

Medication utilization for targeted symptoms in children and adults with fragile X syndrome: US survey.

Bailey DB Jr, Raspa M, Bishop E, Olmsted M, Mallya UG, Berry-Kravis E. Bailey DB Jr, et al. J Dev Behav Pediatr. 2012 Jan;33(1):62-9. doi: 10.1097/DBP.0b013e318236c0e1. J Dev Behav Pediatr. 2012. PMID: 22064563

2

Seizures in fragile X syndrome: characteristics and comorbid diagnoses.

Berry-Kravis E, Raspa M, Loggin-Hester L, Bishop E, Holiday D, Bailey DB. Berry-Kravis E, et al. Am J Intellect Dev Disabil. 2010 Nov;115(6):461-72. doi: 10.1352/1944-7558-115.6.461. Am J Intellect Dev Disabil. 2010. PMID: 20945999

3

Developing a utility index for the Aberrant Behavior Checklist (ABC-C) for fragile X syndrome.

Kerr C, Breheny K, Lloyd A, Brazier J, Bailey DB Jr, Berry-Kravis E, Cohen J, Petrillo J. Kerr C, et al. Qual Life Res. 2015 Feb;24(2):305-14. doi: 10.1007/s11136-014-0759-8. Epub 2014 Jul 26. Qual Life Res. 2015. PMID: 25063082 Free PMC article.

4

Outcome measures for clinical trials in fragile X syndrome.

Berry-Kravis E, Hessl D, Abbeduto L, Reiss AL, Beckel-Mitchener A, Urv TK; Outcome Measures Working Groups. Berry-Kravis E, et al. J Dev Behav Pediatr. 2013 Sep;34(7):508-22. doi: 10.1097/DBP.0b013e31829d1f20. J Dev Behav Pediatr. 2013. PMID: 24042082 Free PMC article.

5

Epilepsy in fragile X syndrome.

Berry-Kravis E. Berry-Kravis E. Dev Med Child Neurol. 2002 Nov;44(11):724-8. doi: 10.1017/s0012162201002833. Dev Med Child Neurol. 2002. PMID: 12418611 Free article.

6

Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis.

Eckert EM, Dominick KC, Pedapati EV, Wink LK, Shaffer RC, Andrews H, Choo TH, Chen C, Kaufmann WE, Tartaglia N, Berry-Kravis EM, Erickson CA. Eckert EM, et al. J Autism Dev Disord. 2019 Nov;49(11):4595-4602. doi: 10.1007/s10803-019-04173-z. J Autism Dev Disord. 2019. PMID: 31468273 Free PMC article.

7

Importance of a specialty clinic for individuals with fragile X syndrome.

Visootsak J, Kidd SA, Anderson T, Bassell JL, Sherman SL, Berry-Kravis EM. Visootsak J, et al. Am J Med Genet A. 2016 Dec;170(12):3144-3149. doi: 10.1002/ajmg.a.37982. Epub 2016 Sep 20. Am J Med Genet A. 2016. PMID: 27649377

8

Psychopharmacology in fragile X syndrome--present and future.

Berry-Kravis E, Potanos K. Berry-Kravis E, et al. Ment Retard Dev Disabil Res Rev. 2004;10(1):42-8. doi: 10.1002/mrdd.20007. Ment Retard Dev Disabil Res Rev. 2004. PMID: 14994287 Review.

9

Preventive care services and health behaviors in children with fragile X syndrome.

Gilbertson KE, Jackson HL, Dziuban EJ, Sherman SL, Berry-Kravis EM, Erickson CA, Valdez R. Gilbertson KE, et al. Disabil Health J. 2019 Oct;12(4):564-573. doi: 10.1016/j.dhjo.2019.04.005. Epub 2019 May 3. Disabil Health J. 2019. PMID: 31118158 Free PMC article.

10

Soy-Based Infant Formula is Associated with an Increased Prevalence of Comorbidities in Fragile X Syndrome.

Westmark CJ, Kniss C, Sampene E, Wang A, Milunovich A, Elver K, Hessl D, Talboy A, Picker J, Haas-Givler B, Esler A, Gropman AL, Uy R, Erickson C, Velinov M, Tartaglia N, Berry-Kravis EM. Westmark CJ, et al. Nutrients. 2020 Oct 14;12(10):3136. doi: 10.3390/nu12103136. Nutrients. 2020. PMID: 33066511 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters